What Is the Life Expectancy and Prognosis for CADASIL?
At a Glance
CADASIL does not have one predictable life expectancy because its symptoms and progression vary widely. Some people remain independent into their 60s and beyond, while blood pressure control, smoking cessation, and regular follow-up can help protect brain health.
In this answer
3 sections
When receiving a CADASIL diagnosis, one of the first questions is often about life expectancy. Currently, the medical literature does not provide a reliable, universal life expectancy calculator that applies to everyone [1].
Historically, some studies cited average life expectancies in the 60s, but these numbers were largely based on early reports of patients who had the most severe symptoms and sought specialized care [1][2]. Modern research reveals that CADASIL is highly variable, and survival estimates from specialized clinics cannot automatically be applied to every person with a pathogenic NOTCH3 variant [3]. While there is no cure to stop the underlying genetic disease, many individuals with the condition maintain their independence well into their 60s and beyond, and proactive management of standard vascular risks can help protect your brain health [4][5].
What These Numbers Can—and Cannot—Tell You
It is important to understand how medical studies report survival. For example, a three-year study of 290 genetically confirmed CADASIL patients (with an average age of about 50) found that 4.8% passed away during the short follow-up period [4]. While this demonstrates high short-term survival for people in mid-life, it is not a lifetime life expectancy estimate and cannot predict your individual future.
Similarly, a large population-based study found that some people carrying the NOTCH3 variants involved in CADASIL had a much milder disease course than typical clinical patients, further highlighting how variable this condition can be depending on the specific genetic variant and other factors [2].
Typical Symptom Timeline (and Why It Varies)
CADASIL is an adult-onset condition, but the symptoms do not follow a fixed or inevitable schedule [1][6]. Different symptoms can overlap, occur out of order, or not happen at all:
- Migraines: For many, migraines with aura are the earliest symptom. These often begin in early adulthood, sometimes appearing years before noticeable changes show up on a brain MRI [6][7].
- Strokes and Cognitive Changes: Ischemic strokes, transient ischemic attacks (TIAs), and subtle cognitive challenges typically emerge in mid-life, often in a person’s 40s or 50s [8][9].
- Later Progression: As the disease advances, repeated strokes and progressive white matter damage can lead to mobility issues (such as gait or walking disturbances), mood disorders, and an increased risk of dementia or severe disability by the 60s or beyond [8][10][4].
⚠️ Emergency Warning: Stroke Symptoms
Never dismiss sudden neurologic symptoms as “just a migraine” or a normal part of CADASIL. If you experience sudden weakness, facial droop, speech or language trouble, sudden vision loss, or balance problems, call emergency services immediately. This applies even to TIAs (brief stroke-like episodes that resolve quickly), as they require emergency medical evaluation to prevent further damage.
Reducing Vascular Risk and Supporting Brain Health
While there is currently no proven treatment to reverse or cure the underlying genetic cause of CADASIL, managing standard vascular risk factors is a critical part of your care. This will not eliminate the disease, but it reduces the overall risk of additional strokes and brain bleeding.
- Individualized Blood Pressure Management: High blood pressure (hypertension) significantly increases the risk of intracerebral hemorrhage (bleeding in the brain) in CADASIL patients [5]. You and your doctor should work together to find a specific blood pressure target that is right for you. Because CADASIL can make the brain sensitive to changes in blood flow, blood pressure should be lowered gradually [11]. Never change your medication doses on your own, and always report if you feel dizzy or lightheaded when standing up.
- Smoking Cessation: Active smoking is strongly associated with faster clinical worsening. In CADASIL studies, smoking was linked to an increased risk of both new strokes and the development of dementia [4]. Quitting smoking is one of the most effective ways to protect your brain.
- Comprehensive Follow-Up: Monitoring your disease involves more than just counting lacunes (small areas of old stroke damage) on an MRI. Regular check-ins with your care team should include assessing your cognition, mood, walking (gait), and overall independence [4]. This allows your doctor to refer you to physical or occupational therapy, adjust migraine or mood treatments, and support your quality of life.
- Genetic Counseling: Because CADASIL is inherited, dealing with a diagnosis can be emotionally taxing for the whole family. Genetic counseling can help you and your relatives navigate testing, family planning, and the emotional weight of uncertainty.
Common questions in this guide
What is the life expectancy for a person with CADASIL?
Does CADASIL always progress on the same timeline?
What can worsen the outlook for someone with CADASIL?
How can I protect my brain and reduce stroke risk with CADASIL?
When should CADASIL symptoms be treated as an emergency?
What monitoring and family support are useful after a CADASIL diagnosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What does my current MRI and clinical exam tell us about my disease progression, and how often should we repeat these assessments?
- 2.What should my individualized daily blood pressure target be, and how can we ensure we lower it safely without causing dizziness?
- 3.What are the warning signs that distinguish a typical migraine aura from a new stroke or TIA that requires an emergency room visit?
- 4.Should I be evaluated by a physical therapist, occupational therapist, or neuropsychologist to establish a baseline for my walking and memory?
- 5.Can you refer my family and me to a genetic counselor to discuss testing and family planning for my relatives?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association.
Meschia JF, Worrall BB, Elahi FM, et al.
Stroke 2023; (54(10)):e452-e464 doi:10.1161/STR.0000000000000444.
PMID: 37602377 - 2
Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population.
Hack RJ, Rutten JW, Person TN, et al.
Stroke 2020; (51(12)):3562-3569 doi:10.1161/STROKEAHA.120.030343.
PMID: 33161844 - 3
CADASIL or NOTCH3 mutaion spectrum diseases? Interpretation of NOTCH3 mutations and clinical heterogeneity in CADASIL.
Wang Y, Liu Y, Mo H, et al.
Frontiers in neurology 2025; (16()):1662012 doi:10.3389/fneur.2025.1662012.
PMID: 41018180 - 4
Predictors of Clinical Worsening in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prospective Cohort Study.
Chabriat H, Hervé D, Duering M, et al.
Stroke 2016; (47(1)):4-11 doi:10.1161/STROKEAHA.115.010696.
PMID: 26578659 - 5
Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?
Chen CH, Cheng YW, Zhang R, et al.
Stroke 2025; (56(8)):2159-2166 doi:10.1161/STROKEAHA.124.050484.
PMID: 40270244 - 6
Recognizing CADASIL: a Secondary Cause of Migraine with Aura.
Burkett JG, Dougherty C
Current pain and headache reports 2017; (21(4)):21 doi:10.1007/s11916-017-0621-0.
PMID: 28281108 - 7
CADASIL: MRI may be normal in the fourth decade of life - a case report.
Samões R, Alves JE, Taipa R, et al.
Cephalalgia : an international journal of headache 2016; (36(11)):1082-1085 doi:10.1177/0333102415618613.
PMID: 26646783 - 8
CADASIL: Imaging Characteristics and Clinical Correlation.
Zhu S, Nahas SJ
Current pain and headache reports 2016; (20(10)):57 doi:10.1007/s11916-016-0584-6.
PMID: 27591799 - 9
Specific Abnormalities in White Matter Pathways as Interface to Small Vessels Disease and Cognition in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Individuals.
Jacobs HIL, Schoemaker D, Torrico-Teave H, et al.
Brain connectivity 2022; (12(1)):52-60 doi:10.1089/brain.2020.0980.
PMID: 33980027 - 10
CADASIL.
Wang MM
Handbook of clinical neurology 2018; (148()):733-743 doi:10.1016/B978-0-444-64076-5.00047-8.
PMID: 29478611 - 11
Acute bilateral multiple subcortical infarcts as manifestation in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Huang H, Xie W, Hu F, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(12)):4391-4399 doi:10.1007/s10072-023-06949-9.
PMID: 37458844
This page explains CADASIL prognosis and life expectancy for informational purposes only and does not constitute medical advice. Your neurologist and genetics team can interpret your MRI, symptoms, and vascular risks in the context of your care.
Get notified when new evidence is published on Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.